Sort
146,196 grants matching “diabetes”
Obesity-induced dysfunction of human MSC in peripheral microvascular repair
$678,004Lilach O Lerman · Mayo Clinic Rochester · R01 · FY2024 · HL
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$677,982Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · DK
The role of irregular sleep schedules as a ubiquitous marker of chronic circadian disruption in cardiometabolic disease development
$677,966Susan S Redline · Brigham And Women'S Hospital · R01 · FY2025 · HL
A Stepped Care Behavioral Intervention Trial for Young Children with T1D
$677,961Randi Streisand · Children'S Research Institute · R01 · FY2019 · DK
Validating Sensor-based Approaches for Monitoring Eating Behavior and Energy Intake by Accounting for Real-World Factors that Impact Accuracy and Acceptability
$677,955Adam Hoover · Clemson University · R01 · FY2023 · DK
Autoimmune Basis of Acquired Lipodystrophies
$677,951Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2025 · DK
LRRC8 anion channels, superoxide and RhoA in diabetic erectile dysfunction
$677,919R Clinton Webb · University Of South Carolina At Columbia · R01 · FY2025 · DK
LRRC8 anion channels, superoxide and RhoA in diabetic erectile dysfunction
$677,919R Clinton Webb · University Of South Carolina At Columbia · R01 · FY2023 · DK
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
$677,913David Matthew Maahs · Stanford University · R18 · FY2021 · DK
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
$677,913David Matthew Maahs · Stanford University · R18 · FY2023 · DK
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
$677,913David Matthew Maahs · Stanford University · R18 · FY2022 · DK
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism
$677,909Kristen Lynn Nowak · University Of Colorado Denver · R01 · FY2025 · DK
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
$677,874John A Dodson · New York University School Of Medicine · R01 · FY2023 · AG
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2023 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · AI
Mechanistic and functional dissection of inflammaging in Down syndrome
$677,851Bernard Khor · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · AI
Hispanic Chronic Renal Insufficiency Cohort(CRIC) Study
$677,840James P Lash · University Of Illinois At Chicago · R01 · FY2013 · DK
Energetic Factors, Lethal Prostate Cancer, and Survivorship
$677,838Jing Ma · Harvard School Of Public Health · U54 · FY2011 · CA
Inflammation and Risk of Diverticulitis
$677,836Andrew T Chan · Massachusetts General Hospital · R01 · FY2016 · DK
Single-cell Analysis of Normal and Perturbed Dynamic Biological Systems
$677,833Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Immunometabolic Regulation of MDSCs in Periodontitis
$677,805Keith L Kirkwood · State University Of New York At Buffalo · R01 · FY2022 · DE
Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
$677,803Mary K. De Groot · Indiana University Indianapolis · R18 · FY2011 · DK
Vaccine immunity and inflammation in the aging person living with HIV
$677,777Anne Elizabeth Parker Frosch · Hennepin Healthcare Research Institute · R01 · FY2024 · AG
HIV Disease and Impairement of High Density Lipoprotein Metabolism
$677,773Michael Ilya Bukrinsky · George Washington University · R01 · FY2013 · HL